hack game slot online android
iShares Bitcoin Trust ( NASDAQ:IBIT – Get Free Report )’s share price were down 2.8% during trading on Thursday . The stock traded as low as $54.06 and last traded at $54.65. Approximately 10,701,888 shares traded hands during mid-day trading, a decline of 70% from the average daily volume of 35,138,418 shares. The stock had previously closed at $56.23. iShares Bitcoin Trust Stock Performance The stock has a 50 day moving average price of $50.39 and a two-hundred day moving average price of $40.46. Institutional Inflows and Outflows Several large investors have recently added to or reduced their stakes in IBIT. IMC Chicago LLC bought a new stake in shares of iShares Bitcoin Trust in the third quarter valued at about $323,337,000. D. E. Shaw & Co. Inc. raised its stake in iShares Bitcoin Trust by 1,657.7% in the 2nd quarter. D. E. Shaw & Co. Inc. now owns 2,636,608 shares of the company’s stock worth $90,014,000 after purchasing an additional 2,486,608 shares in the last quarter. Sculptor Capital LP boosted its holdings in iShares Bitcoin Trust by 188.1% in the 2nd quarter. Sculptor Capital LP now owns 3,392,812 shares of the company’s stock valued at $115,831,000 after purchasing an additional 2,215,107 shares during the period. Aristeia Capital L.L.C. grew its position in shares of iShares Bitcoin Trust by 47.2% during the 2nd quarter. Aristeia Capital L.L.C. now owns 5,940,411 shares of the company’s stock worth $202,806,000 after purchasing an additional 1,903,644 shares in the last quarter. Finally, Point72 Asset Management L.P. bought a new position in shares of iShares Bitcoin Trust during the second quarter worth approximately $56,965,000. About iShares Bitcoin Trust The IShares Bitcoin Trust Registered (IBIT) is an exchange-traded fund that mostly invests in long btc, short usd currency. The fund is a passively managed fund that seeks to track the spot price of Bitcoin. IBIT was launched on Jan 5, 2024 and is issued by BlackRock. Featured Articles Receive News & Ratings for iShares Bitcoin Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Bitcoin Trust and related companies with MarketBeat.com's FREE daily email newsletter .
World Soil Day – Measure, Monitor, ManageFlorida knocks No. 9 Ole Miss out of College Football Playoff contention
Mind Medicine (MindMed) Inc. ( NASDAQ:MNMD – Get Free Report ) insider Dan Karlin sold 6,643 shares of the firm’s stock in a transaction on Thursday, December 26th. The stock was sold at an average price of $7.43, for a total transaction of $49,357.49. Following the completion of the transaction, the insider now directly owns 338,013 shares of the company’s stock, valued at approximately $2,511,436.59. This represents a 1.93 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link . Mind Medicine (MindMed) Stock Down 10.4 % MNMD opened at $6.84 on Friday. The company has a fifty day moving average of $7.25 and a two-hundred day moving average of $6.98. The company has a debt-to-equity ratio of 0.09, a quick ratio of 9.00 and a current ratio of 9.00. Mind Medicine has a fifty-two week low of $3.49 and a fifty-two week high of $12.22. The stock has a market capitalization of $501.59 million, a price-to-earnings ratio of -3.03 and a beta of 2.58. Hedge Funds Weigh In On Mind Medicine (MindMed) A number of hedge funds have recently bought and sold shares of MNMD. JPMorgan Chase & Co. increased its position in shares of Mind Medicine (MindMed) by 8.2% in the third quarter. JPMorgan Chase & Co. now owns 36,995 shares of the company’s stock valued at $211,000 after buying an additional 2,797 shares in the last quarter. Sanctuary Advisors LLC purchased a new stake in Mind Medicine (MindMed) in the 3rd quarter worth $91,000. Barclays PLC raised its position in Mind Medicine (MindMed) by 203.6% during the third quarter. Barclays PLC now owns 136,098 shares of the company’s stock worth $775,000 after acquiring an additional 91,271 shares during the period. Geode Capital Management LLC lifted its holdings in Mind Medicine (MindMed) by 10.8% during the third quarter. Geode Capital Management LLC now owns 1,677,702 shares of the company’s stock valued at $9,548,000 after purchasing an additional 162,933 shares in the last quarter. Finally, XTX Topco Ltd acquired a new stake in shares of Mind Medicine (MindMed) in the third quarter valued at about $337,000. Hedge funds and other institutional investors own 27.91% of the company’s stock. Analysts Set New Price Targets Get Our Latest Report on Mind Medicine (MindMed) Mind Medicine (MindMed) Company Profile ( Get Free Report ) Mind Medicine (MindMed) Inc, a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company’s lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Further Reading Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter .INDIANAPOLIS – There's more than just school pride and bragging rights to all that bellyaching over who might be in and who might be out of college football 's first 12-team playoff. Try the more than $115 million that will be spread across the conferences at the end of the season, all depending on who gets in and which teams go the farthest. Recommended Videos According to the College Football Playoff website , the 12 teams simply making the bracket earn their conferences $4 million each. Another $4 million goes to conferences whose teams get into the quarterfinals. Then, there's $6 million more for teams that make the semifinals and another $6 million for those who play for the title. Most of this bonanza comes courtesy of ESPN, which is forking over $1.3 billion a year to televise the new postseason. A lot of that money is already earmarked — more goes to the Big Ten and Southeastern Conference than the Big 12 or Atlantic Coast — but a lot is up for grabs in the 11 games that will play out between the opening round on Dec. 20 and the final on Jan. 20. In all, the teams that make the title game will bring $20 million to their conferences, all of which distribute that money, along with billions in TV revenue and other sources, in different ways. In fiscal 2022-23, the Big Ten, for instance, reported revenue of nearly $880 million and distributed about $60.5 million to most of its members. The massive stakes might help explain the unabashed lobbying coming from some corners of the football world, as the tension grows in advance of Sunday's final rankings, which will set the bracket. Earlier this week, Big 12 commissioner Brett Yormark lit into the selection committee, which doesn't have a single team higher than 15 in the rankings. That does two things: It positions the Big 12 as a one-bid league, and also threatens to makes its champion — either Arizona State or Iowa State — the fifth-best among conference titlists that get automatic bids. Only the top four of those get byes, which could cost the Big 12 a spot in the quarterfinals — or $4 million. “The committee continues to show time and time again that they are paying attention to logos versus resumes,” Yormark said this week, while slamming the idea of teams with two losses in his conference being ranked worse than teams with three in the SEC. The ACC is also staring at a one-bid season with only No. 8 SMU inside the cut line of this week's projected bracket. Miami's loss last week all but bumped the Hurricanes out of the playoffs, a snub that ACC commissioner Jim Phillips said left him “incredibly shocked and disappointed." “As we look ahead to the final rankings, we hope the committee will reconsider and put a deserving Miami in the field," Phillips said in a statement. The lobbying and bickering filters down to the campuses that feel the impact. And, of course, to social media. One of the most entertaining episodes came earlier this week when athletic directors at Iowa State and SMU went back and forth about whose team was more deserving. There are a few stray millions that the selection committee cannot really influence, including a $3 million payment to conferences that make the playoff. In a reminder that all these kids are going to school, after all, the conferences get $300,000 per football team that meets academic requirements to participate in the postseason. (That's basically everyone). ___ Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-footballCHICAGO (AP) — Chicago Bulls guard Ayo Dosunmu has a strained right calf and will be reevaluated in 10 days. Dosunmu got hurt during Monday night's 112-91 loss to Milwaukee. The Bulls provided an update on his injury on Saturday. Dosunmu, who turns 25 on Jan. 17, is averaging 12.6 points and 4.8 assists in his fourth NBA season. He has appeared in 30 games, including 17 starts. The Chicago native was selected by the Bulls in the second round of the 2021 draft. ___ AP NBA: https://apnews.com/hub/NBA The Associated Press
Automotive Collision Repair Market: Valued at $195.2B in 2022, Projected to Reach $231.2B by 2031